Cargando…

The use of genomics in microbial vaccine development

Vaccination is one of the most effective tools for the prevention of infectious diseases. The availability of complete genome sequences, together with the progression of high-throughput technologies such as functional and structural genomics, has led to a new paradigm in vaccine development. Pan-gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bambini, Stefania, Rappuoli, Rino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108364/
https://www.ncbi.nlm.nih.gov/pubmed/19150507
http://dx.doi.org/10.1016/j.drudis.2008.12.007
_version_ 1783512796547252224
author Bambini, Stefania
Rappuoli, Rino
author_facet Bambini, Stefania
Rappuoli, Rino
author_sort Bambini, Stefania
collection PubMed
description Vaccination is one of the most effective tools for the prevention of infectious diseases. The availability of complete genome sequences, together with the progression of high-throughput technologies such as functional and structural genomics, has led to a new paradigm in vaccine development. Pan-genomic reverse vaccinology, with the comparison of sequence data from multiple isolates of the same species of a pathogen, increases the opportunity of the identification of novel vaccine candidates. Overall, the conventional empiric approach to vaccine development is being replaced by vaccine design. The recent development of synthetic genomics may provide a further opportunity to design vaccines.
format Online
Article
Text
id pubmed-7108364
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71083642020-03-31 The use of genomics in microbial vaccine development Bambini, Stefania Rappuoli, Rino Drug Discov Today Article Vaccination is one of the most effective tools for the prevention of infectious diseases. The availability of complete genome sequences, together with the progression of high-throughput technologies such as functional and structural genomics, has led to a new paradigm in vaccine development. Pan-genomic reverse vaccinology, with the comparison of sequence data from multiple isolates of the same species of a pathogen, increases the opportunity of the identification of novel vaccine candidates. Overall, the conventional empiric approach to vaccine development is being replaced by vaccine design. The recent development of synthetic genomics may provide a further opportunity to design vaccines. Published by Elsevier Ltd. 2009-03 2009-01-15 /pmc/articles/PMC7108364/ /pubmed/19150507 http://dx.doi.org/10.1016/j.drudis.2008.12.007 Text en Copyright © 2009 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bambini, Stefania
Rappuoli, Rino
The use of genomics in microbial vaccine development
title The use of genomics in microbial vaccine development
title_full The use of genomics in microbial vaccine development
title_fullStr The use of genomics in microbial vaccine development
title_full_unstemmed The use of genomics in microbial vaccine development
title_short The use of genomics in microbial vaccine development
title_sort use of genomics in microbial vaccine development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108364/
https://www.ncbi.nlm.nih.gov/pubmed/19150507
http://dx.doi.org/10.1016/j.drudis.2008.12.007
work_keys_str_mv AT bambinistefania theuseofgenomicsinmicrobialvaccinedevelopment
AT rappuolirino theuseofgenomicsinmicrobialvaccinedevelopment
AT bambinistefania useofgenomicsinmicrobialvaccinedevelopment
AT rappuolirino useofgenomicsinmicrobialvaccinedevelopment